TCM
GUTS icon

Triumph Capital Management’s Fractyl Health GUTS Stock Holding History

Triumph Capital Management’s Portfolio GUTS Stock Details GUTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.38K Hold
3,000
– – ﹤0.01% 1537
2026
Q1 		$1.37K Hold
3,000
– – ﹤0.01% 1586
2025
Q4 		$6.6K Buy
+3,000
New +$4.83K ﹤0.01% 1184

Other funds holding GUTS

FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
PM
Phraction Management Colchester, Connecticut $596M AUM 36.77% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.99B AUM 23.61% 1-Year Est. Return
JWCA
J.W. Cole Advisors Tampa, Florida $5.83B AUM 32.38% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Triumph Capital Management's GUTS Position: Q2 2026 in Review

Triumph Capital Management held its Fractyl Health (GUTS) position steady in Q2 2026 at 3,000 shares worth $2.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1537.

Triumph Capital Management first reported a position in GUTS in Q4 2025 and has held it in 3 quarters since. The position peaked at $6.6K in Q4 2025. 6 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Triumph Capital Management held 3,000 shares of Fractyl Health worth $2.38K as of Q2 2026.
  • Triumph Capital Management left its Fractyl Health share count unchanged in Q2 2026.
  • Fractyl Health made up ﹤0.01% of Triumph Capital Management's portfolio in Q2 2026, its #1537 holding.
  • Triumph Capital Management first reported a position in Fractyl Health in Q4 2025 and has held it in 3 quarters since.
  • Triumph Capital Management's Fractyl Health position peaked at $6.6K in Q4 2025.
  • 6 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Triumph Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.